Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor necrosis factor 1B (TNF-1B) mutants and methods of use thereof to screen for candidate therapeutic compounds

Tumor necrosis factor 1B (TNF-1B) mutants and methods of use thereof to screen for candidate therapeutic compounds

US Patent 10717776 · Granted Jul 21, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant variants of PD-1 receptor with selective binding to PD-L1 and uses thereo2025
Compounds and methods for treatment of bacterial infections2025
Engineered PD-1 variants2024
Precision activation of HIV-specific CTLS to eliminate reactivated latent T cell2022
Prevention and treatment of viral infections2022
Engineered PD-1 variants2022
Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and metho2022
Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and metho2022
Broad spectrum viral inhibitor2022
Methods for high throughput receptor:ligand identification2022
Methods for high throughput receptor:ligand identification2022
TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for 2021